Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* age upper to 18 years~* Patients hospitalized in the Service de Néphrologie - Hémodialyse, Transplantations, CHU de Limoges~* Patients requiring chronic hemodialysis~* Patients requiring a treatment by aminoglycosides~* Patients willing to give their written informed consent for their participation to the study~* Patients affiliated to the French social security system or equivalent~Exclusion Criteria:~* Patients under legal protection~* Patients unable or unwilling to provide informed consent and not under legal protection~* Patients deprived of liberty~* Contraindications to gentamicin~* Pregnant or breast-feeding women or women of childbearing potential without efficient contraception (based on declaration)~* Patients with any altered mental status or any psychiatric condition that would interfere with the understanding of the study~* Patients enrolled in another clinical trial testing drugs or therapeutic strategies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- hemodialysis patients (Type: EXPERIMENTAL): The administration of gentamicin at the beginning of the hemodialysis.

Based on this trial design, predict the completion outcome and termination type (if applicable).